 MSN News UK |
UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11
Wall Street Journal … or NICE, Thursday reiterated its earlier decision not to recommend Novartis AG's (NVS) asthma drug Xolair for children aged 6 to 11 years with severe, … Asthma rises as children return to school September marks child asthma peak Children with asthma 'at greater risk during September' |
View full post on asthma – Google News